Kikuchi Y, Saito Y, Nishino S, Uekita Y
Dept. of Radiology Asahikawa Med. College.
Gan No Rinsho. 1990 Oct;36(13):2337-47.
The late effect of normal tissues in altered fractionation was analyzed with our experience and review in clinical trial. In hypofractionation late effect in normal tissues increased in frequency with increased dose per fraction. In the other hand, the optimal ERD or fractionations in MFD were found in larynx, lung and esophagus. The ERD and the frequency of severe late effect in clinical trial with accelerated or accelerated hyperfractionation tended to be less than those of hyperfractionation. However the tolerance ERD in brain and abdominal organ have not been able to determine due to short life span, combined modality and few clinical trial.
结合我们的经验以及对临床试验的回顾,分析了正常组织在分割方式改变时的晚期效应。在超分割放疗中,正常组织的晚期效应发生频率随每次分割剂量的增加而升高。另一方面,在喉、肺和食管中发现了MFD的最佳等效总剂量(ERD)或分割方式。在加速或加速超分割放疗的临床试验中,ERD以及严重晚期效应的发生频率往往低于超分割放疗。然而,由于生存期短、综合治疗方式以及临床试验较少,脑和腹部器官的耐受ERD尚未能够确定。